HK1084883A1 - 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof - Google Patents

2-cyanopyrrolopyrimidines and pharmaceutical uses thereof

Info

Publication number
HK1084883A1
HK1084883A1 HK06105106A HK06105106A HK1084883A1 HK 1084883 A1 HK1084883 A1 HK 1084883A1 HK 06105106 A HK06105106 A HK 06105106A HK 06105106 A HK06105106 A HK 06105106A HK 1084883 A1 HK1084883 A1 HK 1084883A1
Authority
HK
Hong Kong
Prior art keywords
cyanopyrrolopyrimidines
pharmaceutical uses
pharmaceutical
Prior art date
Application number
HK06105106A
Other languages
English (en)
Inventor
Francis Paul Buxton
Takeru Ehara
Pamposh Ganju
Allan Hallett
Ozamu Irie
Atsuko Iwasaki
Takanori Kanazawa
Keiichi Masuya
Kazuhiko Nonomura
Junichi Sakaki
Christopher Robert Snell
Chuanheng Song
Keiko Tanabe
Naoki Teno
Ichiro Umemura
Fumiaki Yokokawa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0302748A external-priority patent/GB0302748D0/en
Priority claimed from GB0304641A external-priority patent/GB0304641D0/en
Priority claimed from GB0304642A external-priority patent/GB0304642D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1084883A1 publication Critical patent/HK1084883A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK06105106A 2003-02-06 2006-04-28 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof HK1084883A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0302748A GB0302748D0 (en) 2003-02-06 2003-02-06 Organic compounds
GB0304641A GB0304641D0 (en) 2003-02-28 2003-02-28 Organic compounds
GB0304642A GB0304642D0 (en) 2003-02-28 2003-02-28 Organic compounds
PCT/EP2004/001081 WO2004069256A1 (en) 2003-02-06 2004-02-05 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof

Publications (1)

Publication Number Publication Date
HK1084883A1 true HK1084883A1 (en) 2006-08-11

Family

ID=32854008

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06105106A HK1084883A1 (en) 2003-02-06 2006-04-28 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof

Country Status (17)

Country Link
US (1) US20060247251A1 (de)
EP (1) EP1592426B1 (de)
JP (1) JP4499667B2 (de)
AR (1) AR043692A1 (de)
AT (1) ATE381335T1 (de)
AU (1) AU2004210422B2 (de)
BR (1) BRPI0407327A (de)
CA (1) CA2514287A1 (de)
DE (1) DE602004010785T2 (de)
ES (1) ES2297378T3 (de)
HK (1) HK1084883A1 (de)
MX (1) MXPA05008348A (de)
PE (1) PE20050068A1 (de)
PL (1) PL378135A1 (de)
PT (1) PT1592426E (de)
TW (1) TW200420566A (de)
WO (1) WO2004069256A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
GB0304640D0 (en) * 2003-02-28 2003-04-02 Novartis Ag Organic compounds
EP1797883A3 (de) * 2003-04-28 2007-08-01 Novartis AG Pharmezeutische Zusammensetzung einen Cathepsin S Inhibitor und ein Opioid enthaltend
AU2005243238B2 (en) * 2004-05-03 2011-11-10 Janssen Pharmaceutica N.V. Novel indole derivatives as selective androgen receptor modulators (SARMS)
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
PE20120493A1 (es) 2009-06-29 2012-05-20 Incyte Corp Pirimidinonas como inhibidores de pi3k
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
UY33304A (es) * 2010-04-02 2011-10-31 Amgen Inc Compuestos heterocíclicos y sus usos
CA2796311A1 (en) 2010-04-14 2011-10-20 Incyte Corporation Fused derivatives as pi3k.delta. inhibitors
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
WO2012012874A1 (en) 2010-07-26 2012-02-02 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
AR084366A1 (es) 2010-12-20 2013-05-08 Incyte Corp N-(1-(fenil sustituido)etil)-9h-purin-6-aminas como inhibidores de pi3k
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
KR101982475B1 (ko) 2011-09-02 2019-05-27 인사이트 홀딩스 코포레이션 Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
CN103304525B (zh) * 2012-03-08 2015-08-05 深圳海王药业有限公司 一种制备达非那新中间体5-(卤代乙基)-2,3-二氢苯并呋喃的方法
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
CA2870527A1 (en) * 2012-04-17 2013-10-24 Astellas Pharma Inc. Nitrogenated bicyclic aromatic heterocyclic compound
AU2013276519B2 (en) 2012-06-15 2017-05-25 Janssen Sciences Ireland Uc 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
US9617289B2 (en) 2012-10-16 2017-04-11 Janssen Sciences Ireland Uc RSV antiviral compounds
WO2014143638A1 (en) * 2013-03-14 2014-09-18 Novartis Ag 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
CN105849090A (zh) 2013-10-30 2016-08-10 诺华股份有限公司 2-苄基-苯并咪唑补体因子b抑制剂及其用途
TWI671299B (zh) 2014-04-14 2019-09-11 愛爾蘭商健生科學愛爾蘭無限公司 作為ｒｓｖ抗病毒化合物之螺脲化合物
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
MY187502A (en) 2015-02-27 2021-09-24 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
US10537552B2 (en) 2015-05-05 2020-01-21 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
MX2020003575A (es) * 2017-10-27 2020-07-22 Esteve Pharmaceuticals Sa Nuevos derivados de alcoxiamino para tratar dolor y estados relacionados con dolor.
TW202024083A (zh) 2018-09-03 2020-07-01 德商拜耳廠股份有限公司 3,9-二氮雜螺[5.5]十一烷化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051577A (en) * 1996-03-15 2000-04-18 Novartis Ag N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof
EP1091738B1 (de) * 1998-06-30 2006-12-06 Eli Lilly And Company BICYCLISCHE sPLA 2-INHIBITOREN
GB0100622D0 (en) * 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
US20030144234A1 (en) * 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
GB0121033D0 (en) * 2001-08-30 2001-10-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
JP4499667B2 (ja) 2010-07-07
EP1592426B1 (de) 2007-12-19
ES2297378T3 (es) 2008-05-01
DE602004010785T2 (de) 2008-12-04
EP1592426A1 (de) 2005-11-09
BRPI0407327A (pt) 2006-01-10
PE20050068A1 (es) 2005-03-11
MXPA05008348A (es) 2005-11-04
DE602004010785D1 (de) 2008-01-31
ATE381335T1 (de) 2008-01-15
PL378135A1 (pl) 2006-03-06
WO2004069256A1 (en) 2004-08-19
TW200420566A (en) 2004-10-16
AU2004210422A1 (en) 2004-08-19
AR043692A1 (es) 2005-08-10
JP2006516554A (ja) 2006-07-06
WO2004069256A8 (en) 2004-10-14
US20060247251A1 (en) 2006-11-02
AU2004210422B2 (en) 2008-01-17
CA2514287A1 (en) 2004-08-19
PT1592426E (pt) 2008-03-13

Similar Documents

Publication Publication Date Title
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
EP1539941A4 (de) Adzyme und deren verwendungen
IL174479A0 (en) Hemiasterlin derivatives and uses thereof
PT1702917T (pt) Derivado de amida e medicamento
EP1682136A4 (de) Therapeutische verbindungen und ihre verwendungen
HK1088837A1 (en) Clk-peptide and slk-peptide
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
AU2003296369A8 (en) Imminoamines and preparation thereof
EP1541174A4 (de) Arzneimittel oder kosmetikum
IL165112A0 (en) Variant integrinpolypeptides and thereof
GB0206505D0 (en) Pharmaceutical combination
AU2003231827A8 (en) Pseudo-tissues and uses thereof
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
GB2401043B (en) Drug
GB0318546D0 (en) Quinoxalinones and their use
HK1209049A1 (en) Survivin-derived peptides and use thereof
GB0201520D0 (en) Pharmaceutical uses
PL373409A1 (en) Pharmaceutical combination
EP1487547A4 (de) Mittel zur körperlichen wechselwirkung und seine verwandten verwendungen
PL355453A1 (en) Pharmaceutical agent
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120205